July 14, 2026
We are pleased to announce a significant milestone in CENTOGENE’s continued commitment to advancing precision medicine in the Middle East: CENTOGENE has taken ownership of Pearl Medical Analysis Laboratory in Abu Dhabi.
As an independent diagnostics provider integrated into CENTOGENE’s global diagnostics platform, Pearl Lab will expand access to advanced reproductive and genetic testing for fertility clinics, women’s health centres, hospitals, physicians, and patients across the region.
By combining Pearl Lab’s established regional presence with CENTOGENE’s global expertise in genetic diagnostics, scientific platform, and team of experienced geneticists and genetic counsellors, we will deliver a broader portfolio of reproductive and genetic testing services, including carrier screening, prenatal diagnostics, and preimplantation genetic testing with shorter turnaround times and the highest quality standards.
This milestone reinforces CENTOGENE’s long-term commitment to the Middle East and our mission to make precision medicine and personalized genetic care more accessible.
We look forward to working closely with healthcare professionals and partners across the region to improve patient outcomes and support families with world-class genetic expertise.
Read the full Press Release
